A comprehensive view of New Drug / Biologic License Application (NDA / BLA). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

European Patent Office Receives Amgen Inc's Patent Application for Engineered NRG-1 Variants with Improved Selectivity Toward Erbb4 But Not Against ERBB3
Published: April 25, 2024 by Pharmaceutical Patent News
Eli Lilly and Company Submits European Patent Application for Peptides Comprising N-Formyl-Halogenated Methionine Residues and Engineered Antibody-Peptide Conjugates Thereof
Published: April 25, 2024 by Biotechnology Patent News
Bristol-Myers Squibb Co Files Patent Application for Crystal form Of 6-(Cyclopropanecarboxamido)-4-((2-Methoxy-3-(1-Methyl-1h- 1,2,4-Triazol-3-Yl) Phenyl)Amino)-N-(Methyl-D3) Pyridazine-3-Carboxamide
Published: April 25, 2024 by Indian Patents News
US Patent Issued to Bristol-Myers Squibb on April 23 for "Substituted bicyclic compounds useful as T cell activators" (American, Indian Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to Regeneron Pharmaceuticals on April 23 for "Methods and compositions for sensitization of tumor cells to immune therapy" (New York, New Jersey Inventors)
Published: April 24, 2024 by U.S. Fed News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count